Key facts
- This page summarizes Mark S. Forman's Form 4 filing for Ventyx Biosciences, Inc. (VTYX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Aug 2024, 16:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
25% of the shares subject to the Option shall vest on the one year anniversary of the date of grant (the "Vesting Commencement Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.